{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:13:50Z","timestamp":1794557630632,"version":"4.9.1"},"reference-count":143,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:p>Despite the availability of a vaccine, pertussis is a particularly difficult disease to control. Improvements in molecular diagnosis, changes in vaccine components, and missed opportunities for vaccination have resulted in rising pertussis disease incidence. Young infants are at the highest risk of severe complications and mortality, but immunization of mothers during pregnancy can provide protection. The presentation of infant pertussis differs somewhat from the traditional catarrhal, paroxysmal, and convalescent stages seen in adults. By understanding the clinical presentation of pertussis in all age groups, providers can more quickly prescribe appropriate antibiotic therapy and postexposure prophylaxis. Providers are also an essential source of evidence-based vaccination counseling for pregnant women and families, and understanding the complications of this disease is an important part of these sometimes difficult but critical conversations.<\/jats:p>","DOI":"10.1542\/peds.2025-072868","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:02:56Z","timestamp":1759449776000},"source":"Crossref","is-referenced-by-count":4,"title":["What\u2019s Old Is New Again: Pertussis"],"prefix":"10.1542","volume":"156","author":[{"given":"Caitlin","family":"Naureckas Li","sequence":"first","affiliation":[{"name":"1Division of Infectious Diseases, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"2Division of Infectious Diseases, Department of Pediatrics, School of Medicine, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon L.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"3Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"4Division of Pediatric Infectious Diseases, Norton Children\u2019s and the University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Parker","sequence":"additional","affiliation":[{"name":"5Division of Pediatric Infectious Diseases, Children\u2019s Hospital Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mary","family":"Healy","sequence":"additional","affiliation":[{"name":"3Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"38","key":"2025103119572130900_r1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.15585\/mmwr.mm7338a3","article-title":"Decline in vaccination coverage by age 24\u00a0months and vaccination inequities among children born in 2020 and 2021 - National Immunization Survey-Child, United States, 2021\u20132023","volume":"73","author":"Hill","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"43","key":"2025103119572130900_r2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.15585\/mmwr.mm7343a4","article-title":"Routine vaccination coverage - worldwide, 2023","volume":"73","author":"Jones","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"11","key":"2025103119572130900_r3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2016.1353","article-title":"Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis","volume":"315","author":"Phadke","year":"2016","journal-title":"JAMA."},{"issue":"24","key":"2025103119572130900_r4","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1001\/jama.284.24.3145","article-title":"Individual and community risks of measles and pertussis associated with personal exemptions to immunization","volume":"284","author":"Feikin","year":"2000","journal-title":"JAMA."},{"issue":"6","key":"2025103119572130900_r5","doi-asserted-by":"crossref","first-page":"e2025071332","DOI":"10.1542\/peds.2025-071332","article-title":"What\u2019s old is new again: measles","volume":"155","author":"Naureckas Li","year":"2025","journal-title":"Pediatrics."},{"issue":"3","key":"2025103119572130900_r6","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00164-22","article-title":"Bordetella bronchiseptica and Bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations","volume":"36","author":"Miguelena Chamorro","year":"2023","journal-title":"Clin Microbiol Rev."},{"issue":"1","key":"2025103119572130900_r7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diagmicrobio.2015.01.011","article-title":"Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica","volume":"82","author":"Garc\u00eda-de-la-Fuente","year":"2015","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"6","key":"2025103119572130900_r8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(14)70021-0","article-title":"Bordetella holmesii: an under-recognised Bordetella species","volume":"14","author":"Pittet","year":"2014","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"2025103119572130900_r9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00006454-199404000-00011","article-title":"Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis","volume":"13","author":"Heininger","year":"1994","journal-title":"Pediatr Infect Dis J."},{"issue":"4","key":"2025103119572130900_r10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.36.4.999-1002.1998","article-title":"Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates","volume":"36","author":"Mastrantonio","year":"1998","journal-title":"J Clin Microbiol."},{"issue":"7","key":"2025103119572130900_r11","doi-asserted-by":"crossref","first-page":"ftw087","DOI":"10.1093\/femspd\/ftw087","article-title":"Pertussis leukocytosis: mechanisms, clinical relevance and treatment","volume":"74","author":"Carbonetti","year":"2016","journal-title":"Pathog Dis."},{"issue":"23","key":"2025103119572130900_r12","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1111\/j.1742-4658.2011.08237.x","article-title":"The ins and outs of pertussis toxin","volume":"278","author":"Locht","year":"2011","journal-title":"FEBS J."},{"issue":"2","key":"2025103119572130900_r13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev."},{"issue":"7","key":"2025103119572130900_r14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2025103119572130900_r15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/jit639","article-title":"Pertussis pathogenesis--what we know and what we don\u2019t know","volume":"209","author":"Hewlett","year":"2014","journal-title":"J Infect Dis."},{"issue":"8","key":"2025103119572130900_r16","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1073\/pnas.86.8.2637","article-title":"Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence","volume":"86","author":"Relman","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025103119572130900_r17","volume-title":"Principles and Practice of Pediatric Infectious Diseases","author":"Long","year":"2023","edition":"6th ed"},{"issue":"7","key":"2025103119572130900_r18","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1128\/IAI.00188-10","article-title":"Pertactin is required for Bordetella species to resist neutrophil-mediated clearance","volume":"78","author":"Inatsuka","year":"2010","journal-title":"Infect Immun."},{"issue":"9","key":"2025103119572130900_r19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1348-0421.1990.tb01057.x","article-title":"Hemagglutination activities of purified pertussis toxin and filamentous hemagglutinin against erythrocytes from various animals","volume":"34","author":"Gupta","year":"1990","journal-title":"Microbiol Immunol."},{"key":"2025103119572130900_r20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front Immunol."},{"issue":"9","key":"2025103119572130900_r21","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1172\/JCI121309","article-title":"Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters","volume":"128","author":"da Silva Antunes","year":"2018","journal-title":"J Clin Invest."},{"key":"2025103119572130900_r22","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3389\/fimmu.2018.03068","article-title":"The role of mucosal immunity in pertussis","volume":"9","author":"Solans","year":"2019","journal-title":"Front Immunol."},{"key":"2025103119572130900_r23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coi.2019.03.006","article-title":"Pertussis vaccines and protective immunity","volume":"59","author":"Kapil","year":"2019","journal-title":"Curr Opin Immunol."},{"issue":"4","key":"2025103119572130900_r24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/infdis\/166.4.908","article-title":"The longevity of the immune response to filamentous hemagglutinin and pertussis toxin in patients with pertussis in a semiclosed community","volume":"166","author":"Tomoda","year":"1992","journal-title":"J Infect Dis."},{"issue":"6","key":"2025103119572130900_r25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med."},{"issue":"1","key":"2025103119572130900_r26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA."},{"issue":"3","key":"2025103119572130900_r27","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics."},{"key":"2025103119572130900_r28","article-title":"Pertussis cases by year (1922\u20132023)","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"6","key":"2025103119572130900_r29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1542\/peds.81.6.933","article-title":"Report of the Task Force on Pertussis and Pertussis Immunization\u20141988","volume":"81","author":"Cherry","year":"1988","journal-title":"Pediatrics."},{"issue":"2","key":"2025103119572130900_r30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14760584.4.2.173","article-title":"Acellular pertussis vaccines in Japan: past, present and future","volume":"4","author":"Watanabe","year":"2005","journal-title":"Expert Rev Vaccines."},{"issue":"4","key":"2025103119572130900_r31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"2025103119572130900_r32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/adc.49.1.46","article-title":"Neurological complications of pertussis inoculation","volume":"49","author":"Kulenkampff","year":"1974","journal-title":"Arch Dis Child."},{"issue":"1","key":"2025103119572130900_r33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036242","article-title":"Whooping cough and whooping cough vaccine: the risks and benefits debate","volume":"4","author":"Miller","year":"1982","journal-title":"Epidemiol Rev."},{"issue":"2","key":"2025103119572130900_r34","first-page":"1","article-title":"The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study","volume":"14","author":"Cherry","year":"1984","journal-title":"Curr Probl Pediatr."},{"issue":"8369","key":"2025103119572130900_r35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet."},{"issue":"1 Pt 1","key":"2025103119572130900_r36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics."},{"issue":"2","key":"2025103119572130900_r37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/biol.1999.0184","article-title":"Overview of recent clinical trials of acellular pertussis vaccines","volume":"27","author":"Miller","year":"1999","journal-title":"Biologicals."},{"issue":"15","key":"2025103119572130900_r38","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine."},{"issue":"9091","key":"2025103119572130900_r39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet."},{"issue":"10","key":"2025103119572130900_r40","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciy757","article-title":"The Epidemiology of nationally reported pertussis in the United States, 2000\u20132016","volume":"68","author":"Skoff","year":"2019","journal-title":"Clin Infect Dis."},{"key":"2025103119572130900_r41","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1017\/S0950268819000761","article-title":"On the role of different age groups during pertussis epidemics in California, 2010 and 2014","volume":"147","author":"Mahmud","year":"2019","journal-title":"Epidemiol Infect."},{"key":"2025103119572130900_r42","article-title":"About diphtheria, tetanus, and pertussis vaccines","author":"Centers for Disease Control and Prevention","year":"2022"},{"issue":"6","key":"2025103119572130900_r43","doi-asserted-by":"crossref","first-page":"e20161414","DOI":"10.1542\/peds.2016-1414","article-title":"School entry requirements and coverage of nontargeted adolescent vaccines","volume":"138","author":"Moss","year":"2016","journal-title":"Pediatrics."},{"issue":"9","key":"2025103119572130900_r44","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2105\/AJPH.2009.179341","article-title":"Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade","volume":"100","author":"Kharbanda","year":"2010","journal-title":"Am J Public Health."},{"key":"2025103119572130900_r45","article-title":"2024 provisional pertussis surveillance report","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"2","key":"2025103119572130900_r46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/504803","article-title":"Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)","volume":"43","author":"Ward","year":"2006","journal-title":"Clin Infect Dis."},{"key":"2025103119572130900_r47","article-title":"Pertussis reported cases and incidence","author":"World Health Organization"},{"issue":"7","key":"2025103119572130900_r48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14787210.2016.1190272","article-title":"Surveillance of pertussis: methods and implementation","volume":"14","author":"Guiso","year":"2016","journal-title":"Expert Rev Anti Infect Ther."},{"key":"2025103119572130900_r49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijid.2019.07.016","article-title":"Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges","volume":"87","author":"Thisyakorn","year":"2019","journal-title":"Int J Infect Dis."},{"issue":"suppl 4","key":"2025103119572130900_r50","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/cid\/ciw529","article-title":"Global childhood deaths from pertussis: a historical review","volume":"63","author":"Chow","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"10183","key":"2025103119572130900_r51","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(19)30226-0","article-title":"Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000\u20132016: a spatial and temporal modelling study","volume":"393","author":"Mosser","year":"2019","journal-title":"Lancet."},{"issue":"12)(suppl 2","key":"2025103119572130900_r52","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/infdis\/jiaa469","article-title":"Pertussis (whooping cough)","volume":"224","author":"Decker","year":"2021","journal-title":"J Infect Dis."},{"key":"2025103119572130900_r53","volume-title":"Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases","author":"Cherry","year":"2019","edition":"8th ed"},{"issue":"12","key":"2025103119572130900_r54","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1086\/320754","article-title":"Pertussis is a frequent cause of prolonged cough illness in adults and adolescents","volume":"32","author":"Senzilet","year":"2001","journal-title":"Clin Infect Dis."},{"issue":"3","key":"2025103119572130900_r55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/161.3.480","article-title":"Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology","volume":"161","author":"Long","year":"1990","journal-title":"J Infect Dis."},{"issue":"10","key":"2025103119572130900_r56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/00006454-199010000-00003","article-title":"Serologic evidence of subclinical pertussis in immunized children","volume":"9","author":"Long","year":"1990","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"2025103119572130900_r57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/cid\/ciz531","article-title":"Asymptomatic infection and transmission of pertussis in households: a systematic review","volume":"70","author":"Craig","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2025103119572130900_r58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"2025103119572130900_r59","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin Infect Dis."},{"key":"2025103119572130900_r60","article-title":"Laboratory testing for pertussis","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"3","key":"2025103119572130900_r61","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1542\/peds.105.3.e31","article-title":"Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial","volume":"105","author":"Heininger","year":"2000","journal-title":"Pediatrics."},{"issue":"8","key":"2025103119572130900_r62","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/JCM.40.8.2801-2805.2002","article-title":"Issues associated with and recommendations for using PCR to detect outbreaks of pertussis","volume":"40","author":"Lievano","year":"2002","journal-title":"J Clin Microbiol."},{"issue":"10","key":"2025103119572130900_r63","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/jcm.35.10.2435-2443.1997","article-title":"Laboratory diagnosis of pertussis: state of the art in 1997","volume":"35","author":"M\u00fcller","year":"1997","journal-title":"J Clin Microbiol."},{"issue":"4","key":"2025103119572130900_r64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CMR.00031-15","article-title":"Laboratory diagnosis of pertussis","volume":"28","author":"van der Zee","year":"2015","journal-title":"Clin Microbiol Rev."},{"key":"2025103119572130900_r65","first-page":"656","volume-title":"Red Book: 2024\u20132027 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2024","edition":"33rd ed"},{"issue":"3","key":"2025103119572130900_r66","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"1","key":"2025103119572130900_r67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/315648","article-title":"Morbidity of pertussis in adolescents and adults","volume":"182","author":"De Serres","year":"2000","journal-title":"J Infect Dis."},{"issue":"5)(suppl","key":"2025103119572130900_r68","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/01.inf.0000160912.58660.87","article-title":"Health burden of pertussis in adolescents and adults","volume":"24","author":"Rothstein","year":"2005","journal-title":"Pediatr Infect Dis J."},{"issue":"11","key":"2025103119572130900_r69","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1086\/425006","article-title":"Societal costs and morbidity of pertussis in adolescents and adults","volume":"39","author":"Lee","year":"2004","journal-title":"Clin Infect Dis."},{"issue":"12","key":"2025103119572130900_r70","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMcp041025","article-title":"Clinical practice. Pertussis--not just for kids","volume":"352","author":"Hewlett","year":"2005","journal-title":"N Engl J Med."},{"issue":"28","key":"2025103119572130900_r71","first-page":"525","article-title":"Pertussis\u2013United States, January 1992-June 1995","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","journal-title":"MMWR Morb Wkly Rep."},{"issue":"6","key":"2025103119572130900_r72","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/clinids\/13.6.1043","article-title":"Pertussis encephalopathy in an adult: case report and review","volume":"13","author":"Halperin","year":"1991","journal-title":"Rev Infect Dis."},{"issue":"1","key":"2025103119572130900_r73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/344776","article-title":"Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review","volume":"36","author":"Skowronski","year":"2003","journal-title":"Clin Infect Dis."},{"issue":"5)(suppl","key":"2025103119572130900_r74","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.inf.0000160929.35004.86","article-title":"Economic burden of pertussis and the impact of immunization","volume":"24","author":"Caro","year":"2005","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"2025103119572130900_r75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciw633","article-title":"Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"22","key":"2025103119572130900_r76","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.290.22.2968","article-title":"Trends in pertussis among infants in the United States, 1980\u20131999","volume":"290","author":"Tanaka","year":"2003","journal-title":"JAMA."},{"issue":"suppl 4","key":"2025103119572130900_r77","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/cid\/ciw550","article-title":"Pertussis in young infants throughout the world","volume":"63","author":"Cherry","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2025103119572130900_r78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/000992288602500109","article-title":"Pertussis complicated by the syndrome of inappropriate antidiuretic hormone secretion. Pathophysiology and management","volume":"25","author":"Matherne","year":"1986","journal-title":"Clin Pediatr (Phila)."},{"issue":"4","key":"2025103119572130900_r79","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.pec.0000086240.54586.04","article-title":"Pertussis pneumonia complicated by a hyponatremic seizure","volume":"19","author":"Abe","year":"2003","journal-title":"Pediatr Emerg Care."},{"issue":"6","key":"2025103119572130900_r80","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/adc.63.6.598","article-title":"Severe hypoxaemia in pertussis","volume":"63","author":"Southall","year":"1988","journal-title":"Arch Dis Child."},{"key":"2025103119572130900_r81","article-title":"Louisiana Department of Health","author":"Whooping cough cases remain high across Louisiana","year":"2025"},{"issue":"1","key":"2025103119572130900_r82","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.114.1.e9","article-title":"A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants","volume":"114","author":"Heininger","year":"2004","journal-title":"Pediatrics."},{"issue":"5","key":"2025103119572130900_r83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s004310050626","article-title":"Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities","volume":"156","author":"Lindgren","year":"1997","journal-title":"Eur J Pediatr."},{"issue":"3","key":"2025103119572130900_r84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1542\/peds.2014-2026","article-title":"Azithromycin in early infancy and pyloric stenosis","volume":"135","author":"Eberly","year":"2015","journal-title":"Pediatrics."},{"issue":"6","key":"2025103119572130900_r85","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/INF.0b013e31828c3bb3","article-title":"Exchange blood transfusion in the management of severe pertussis in young infants","volume":"32","author":"Nieves","year":"2013","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"2025103119572130900_r86","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1093\/jpids\/pix044","article-title":"Treatment of pertussis-2017","volume":"7","author":"Cherry","year":"2018","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"3","key":"2025103119572130900_r87","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/INF.0000000000001710","article-title":"An observational study of severe pertussis in 100 infants \u2264120\u00a0days of age","volume":"37","author":"Cherry","year":"2018","journal-title":"Pediatr Infect Dis J."},{"issue":"4","key":"2025103119572130900_r88","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181fe4058","article-title":"The Collaborative Pediatric Critical Care Research Network Critical Pertussis Study: collaborative research in pediatric critical care medicine","volume":"12","author":"Burr","year":"2011","journal-title":"Pediatr Crit Care Med."},{"key":"2025103119572130900_r89","first-page":"282","article-title":"Studies on experimental infection with Bordetella pertussis, effect of cortisone on the infection and immunity in mice","volume":"33","author":"Iida","year":"1963","journal-title":"Jpn J Exp Med."},{"issue":"2","key":"2025103119572130900_r90","first-page":"e1218","article-title":"Hydroxyurea for malignant pertussis in critically ill children","volume":"7","author":"Blanc","year":"2025","journal-title":"Crit Care Explor."},{"key":"2025103119572130900_r91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fped.2018.00261","article-title":"Leukemoid reaction in infant pertussis: is there a place for hydroxyurea? A case report","volume":"6","author":"Maitre","year":"2018","journal-title":"Front Pediatr."},{"key":"2025103119572130900_r92","article-title":"Manual for the Surveillance of Vaccine-Preventable Diseases","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025103119572130900_r93","article-title":"Pertussis","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"RR-7","key":"2025103119572130900_r94","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Recomm Rep."},{"key":"2025103119572130900_r95","unstructured":"Centers for Disease Control and Prevention\n          . Postexposure antimicrobial prophylaxis. Published April 2, 2024. Accessed April 15, 2025. https:\/\/www.cdc.gov\/pertussis\/php\/postexposure-prophylaxis\/index.html"},{"key":"2025103119572130900_r96","unstructured":"Centers for Disease Control and Prevention\n          . Immunization schedules. Published May 29, 2025. Accessed August 11, 2025. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/index.html"},{"issue":"2","key":"2025103119572130900_r97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep."},{"issue":"6","key":"2025103119572130900_r98","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.vaccine.2019.11.074","article-title":"Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged \u226565\u00a0years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018","volume":"38","author":"Haber","year":"2020","journal-title":"Vaccine."},{"issue":"1","key":"2025103119572130900_r99","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1542\/peds.105.1.e12","article-title":"Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines","volume":"105","author":"Rennels","year":"2000","journal-title":"Pediatrics."},{"issue":"2","key":"2025103119572130900_r100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.2009-1496","article-title":"Lack of association between acellular pertussis vaccine and seizures in early childhood","volume":"126","author":"Huang","year":"2010","journal-title":"Pediatrics."},{"issue":"6","key":"2025103119572130900_r101","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1542\/peds.2008-1977","article-title":"A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization","volume":"122","author":"Zangwill","year":"2008","journal-title":"Pediatrics."},{"issue":"25","key":"2025103119572130900_r102","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1016\/j.vaccine.2014.03.063","article-title":"Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine","volume":"32","author":"Daley","year":"2014","journal-title":"Vaccine."},{"issue":"4","key":"2025103119572130900_r103","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","article-title":"Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998","volume":"106","author":"DuVernoy","year":"2000","journal-title":"Pediatrics."},{"issue":"3","key":"2025103119572130900_r104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"2025103119572130900_r105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2019.09.104","article-title":"Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States","volume":"38","author":"Havers","year":"2020","journal-title":"Vaccine."},{"issue":"5","key":"2025103119572130900_r106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI100987","article-title":"An attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy","volume":"17","author":"Lichty","year":"1938","journal-title":"J Clin Invest."},{"issue":"8","key":"2025103119572130900_r107","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2016.1171948","article-title":"Pertussis vaccination in pregnancy","volume":"12","author":"Healy","year":"2016","journal-title":"Hum Vaccin Immunother."},{"issue":"1","key":"2025103119572130900_r108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cid\/cir765","article-title":"Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection","volume":"54","author":"Castagnini","year":"2012","journal-title":"Clin Infect Dis."},{"issue":"3","key":"2025103119572130900_r109","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cid\/cir836","article-title":"The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization","volume":"54","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2025103119572130900_r110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/cis923","article-title":"Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants","volume":"56","author":"Healy","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"3","key":"2025103119572130900_r111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijgo.15311","article-title":"The current state of pertussis vaccination in pregnancy around the world, with recommendations for improved care: consensus statements from the Global Pertussis Initiative","volume":"165","author":"Olson-Chen","year":"2024","journal-title":"Int J Gynaecol Obstet."},{"issue":"12","key":"2025103119572130900_r112","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/cix724","article-title":"Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants &lt;2\u00a0months of age: a case-control evaluation","volume":"65","author":"Skoff","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2025103119572130900_r113","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis."},{"issue":"5","key":"2025103119572130900_r114","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics."},{"issue":"40","key":"2025103119572130900_r115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.15585\/mmwr.mm6840e1","article-title":"Vital signs: burden and prevention of influenza and pertussis among pregnant women and infants - United States","volume":"68","author":"Lindley","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"4","key":"2025103119572130900_r116","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr."},{"issue":"5","key":"2025103119572130900_r117","doi-asserted-by":"crossref","first-page":"e2023062664","DOI":"10.1542\/peds.2023-062664","article-title":"Maternal pertussis vaccination, infant immunization, and risk of pertussis","volume":"152","author":"Regan","year":"2023","journal-title":"Pediatrics."},{"issue":"17","key":"2025103119572130900_r118","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA."},{"issue":"11","key":"2025103119572130900_r119","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis."},{"key":"2025103119572130900_r120","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ."},{"issue":"3","key":"2025103119572130900_r121","doi-asserted-by":"crossref","first-page":"e20180120","DOI":"10.1542\/peds.2018-0120","article-title":"Prenatal tetanus, diphtheria, acellular pertussis vaccination and autism spectrum disorder","volume":"142","author":"Becerra-Culqui","year":"2018","journal-title":"Pediatrics."},{"issue":"3","key":"2025103119572130900_r122","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/cid\/ciy517","article-title":"The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012\u20132015: the FluMum Study","volume":"68","author":"McHugh","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"3","key":"2025103119572130900_r123","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1093\/cid\/ciac432","article-title":"Maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during pregnancy: impact on infant anti-pertussis antibody concentrations by maternal pertussis priming series","volume":"76","author":"Havers","year":"2023","journal-title":"Clin Infect Dis."},{"issue":"5","key":"2025103119572130900_r124","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J Clin Invest."},{"issue":"36","key":"2025103119572130900_r125","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2017.11.055","article-title":"Will we have new pertussis vaccines?","volume":"36","author":"Locht","year":"2018","journal-title":"Vaccine."},{"issue":"1","key":"2025103119572130900_r126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live Attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis."},{"issue":"11","key":"2025103119572130900_r127","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S1473-3099(18)30375-X","article-title":"Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2\/3 randomised, controlled, non-inferiority trial","volume":"18","author":"Pitisuttithum","year":"2018","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"2025103119572130900_r128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1473-3099(17)30612-6","article-title":"A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2\/3, randomised controlled non-inferiority trial","volume":"18","author":"Sricharoenchai","year":"2018","journal-title":"Lancet Infect Dis."},{"issue":"39","key":"2025103119572130900_r129","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2017.08.009","article-title":"Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model","volume":"35","author":"Misiak","year":"2017","journal-title":"Vaccine."},{"issue":"7","key":"2025103119572130900_r130","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","article-title":"Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity","volume":"14","author":"Raeven","year":"2015","journal-title":"J Proteome Res."},{"key":"2025103119572130900_r131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fcimb.2019.00125","article-title":"A pertussis outer membrane vesicle-based vaccine induces lung-resident memory CD4\u00a0T cells and protection against Bordetella pertussis, including pertactin deficient strains","volume":"9","author":"Zurita","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"issue":"8","key":"2025103119572130900_r132","doi-asserted-by":"crossref","first-page":"e0052023","DOI":"10.1128\/iai.00520-23","article-title":"Immunization with an mRNA DTP vaccine protects against pertussis in rats","volume":"92","author":"Bitzer","year":"2024","journal-title":"Infect Immun."},{"issue":"1","key":"2025103119572130900_r133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41541-024-00890-4","article-title":"Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice","volume":"9","author":"Wolf","year":"2024","journal-title":"NPJ Vaccines."},{"key":"2025103119572130900_r134","unstructured":"Centers for Disease Control and Prevention\n          . Vaccination coverage and exemptions among kindergartners. Published July 31, 2025. Accessed August 11, 2025. https:\/\/www.cdc.gov\/schoolvaxview\/data\/index.html"},{"key":"2025103119572130900_r135","article-title":"Ten threats to global health in 2019","author":"World Health Organization"},{"key":"2025103119572130900_r136","doi-asserted-by":"crossref","first-page":"126631","DOI":"10.1016\/j.vaccine.2024.126631","article-title":"Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates","volume":"45","author":"Moghtaderi","year":"2025","journal-title":"Vaccine."},{"issue":"3","key":"2025103119572130900_r137","doi-asserted-by":"crossref","first-page":"e2023065483","DOI":"10.1542\/peds.2023-065483","article-title":"Strategies for improving vaccine communication and uptake","volume":"153","author":"O\u2019Leary","year":"2024","journal-title":"Pediatrics."},{"issue":"6","key":"2025103119572130900_r138","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp2313742","article-title":"The risks of normalizing parental vaccine hesitancy","volume":"390","author":"Higgins","year":"2024","journal-title":"N Engl J Med."},{"issue":"39","key":"2025103119572130900_r139","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7239a4","article-title":"Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women - United States, April 2023","volume":"72","author":"Razzaghi","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2025103119572130900_r140","doi-asserted-by":"crossref","first-page":"127329","DOI":"10.1016\/j.vaccine.2025.127329","article-title":"Trends in Tdap and influenza vaccination in pregnancy relative to the coronavirus disease-19 pandemic","volume":"61","author":"Dave","year":"2025","journal-title":"Vaccine."},{"issue":"2","key":"2025103119572130900_r141","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijgo.14981","article-title":"Vaccination during pregnancy: a golden opportunity to embrace","volume":"163","author":"Amaral","year":"2023","journal-title":"Int J Gynaecol Obstet."},{"issue":"36","key":"2025103119572130900_r142","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.15585\/mmwr.mm6436a2","article-title":"Influenza vaccination coverage among pregnant women--United States, 2014\u201315 influenza season","volume":"64","author":"Ding","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2025103119572130900_r143","article-title":"Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination","author":"Committee on Obstetric Practice; Immunization and Emerging Infections Expert Work Group","year":"2017"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-072868\/1856939\/pediatrics.2025072868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-072868\/1856939\/pediatrics.2025072868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:57:42Z","timestamp":1761955062000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/156\/5\/e2025072868\/204391\/What-s-Old-Is-New-Again-Pertussis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":143,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,3]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-072868","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"article-number":"e2025072868"}}